We are leveraging our
knowledge of new autophagy
biology to create new therapeutics

Our Science
The mission of Samsara is to identify new therapeutics for difficult to treat diseases such as rare genetic disease and neurodegenerative disorders. We do that by discovering new molecules that restore or induce the process of cellular autophagy.
Our strategy to identify molecules that influence autophagy is via an unbiased screening approach coupled with techniques that enable us to understand mechanism and target. In this way we are uncovering new biology and ultimately powerful and novel therapeutic agents.
Meet the Neuro Team – Modelling Neurodegeneration in a Dish
We caught up with Senior Scientists Gabriela Vilema Enríquez and Matthew Williamson on their work within the neuroscience team at Samsara.
CMT Research Foundation and Samsara Therapeutics Partner on a Novel Therapeutic Approach for CMT1A
CMT Research Foundation and Samsara Therapeutics Partner on a Novel Therapeutic Approach for CMT1A with the Potential to Reach Clinical Trials
Meet Nicole – From Books to Bench
Hear from Nicole Mak, a Biology student at Bath University, on her year in industry with Samsara.
Samsara Therapeutics Establishes Scientific Advisory Board
Michael Schlossmacher, Susan Perlman, Ed Tate and Christian Behl to help advance development of neurodegeneration and rare genetic disease therapeutics
© 2021 Samsara Therapeutics | Legal Information | Privacy
© 2021 Samsara Therapeutics
Legal Information | Privacy